# A Study of XZB-0004 in Patients With Solid Tumors

> **NCT05772455** · PHASE1 · RECRUITING · sponsor: **Xuanzhu Biopharmaceutical Co., Ltd.** · enrollment: 128 (estimated)

## Conditions studied

- Advanced Solid Tumor
- NSCLC

## Interventions

- **DRUG:** XZB-0004

## Key facts

- **NCT ID:** NCT05772455
- **Lead sponsor:** Xuanzhu Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-24
- **Primary completion:** 2025-06
- **Final completion:** 2027-02
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772455, "A Study of XZB-0004 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05772455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*